MedTrace Logo

Oral and Anal Swab Sampling in Patients With HPV Positivity

NCT06906913 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2025-04-02

No results posted yet for this study

Summary

Patients whose pathology results are reported as cervical intraepithelial neoplasia (CIN) 1, CIN 2, and CIN 3, are recruited. We aimed to evaluate HPV-positive women presenting to the Obstetrics and Gynecology clinic, whose cervical pathology results were reported as CIN 1, CIN 2, and CIN 3, by collecting oropharyngeal and anal swab samples. A total of 30 women of reproductive age, who consented to participate, were included in the study.

Conditions

Interventions

DIAGNOSTIC_TEST

HPV testing

Oropharyngeal and anal swab samples are evaluated in the Microbiology laboratory for the existence of HPV.

Sponsors & Collaborators

  • gaziantep university medicine faculty

    collaborator UNKNOWN

  • Medipol University

    lead OTHER

Principal Investigators

  • Neslihan Bayramoglu Tepe, Doctor of Medicine · University of Gaziantep

  • Ozan Dogan, Prof. Dr. · Istanbul Nisantasi University

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-03-14
Primary Completion
2024-07-31
Completion
2024-11-19

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06906913 on ClinicalTrials.gov